| |
|
|
|
Xtalks, Online
2025-01-22
Are you measuring what matters in pediatric epilepsy trials?
Many clinical trials in pediatric epilepsies quantify seizures as an endpoint. However, change, in some patients, is more subtle than can be measured by a seizure diary. This webinar will bring together seasoned experts in clinical trial operations and strategy, alongside patient advocacy and public health professionals, to delve into the evolving landscape of clinical trial endpoints for pediatric epilepsies.
Traditional clinical trials for pediatric epilepsy often rely on seizure frequency as the primary endpoint. However, this approach does not always capture the full spectrum of patient experiences, especially when changes are subtler than what seizure diaries can document. This webinar is set to address this pivotal issue, focusing on the need for more comprehensive and patient-centered endpoints.
Participants will gain valuable insights into the current trends in endpoint development, particularly for developmental and epileptic encephalopathies (DEE). These insights will not only reflect the latest scientific advancements but also incorporate the nuanced perspectives of those living with these conditions. The key learning points for the audience will include:
Trends in endpoints for DEE
Broadening the scope of clinical trial endpoints: Seizure diaries are commonly used as endpoints in pediatric epilepsy trials but these measures may not capture subtle and meaningful changes in some patients, and this webinar explores trends in developing more nuanced and patient-centric endpoints
Transforming challenges into actionable research: The webinar will emphasize how families, advocacy groups and researchers can collaborate to identify measurable, impactful outcomes that reflect the lived experiences of children with rare epilepsies
This webinar can push the boundaries of research to accommodate the diverse and real-world needs of young patients and their families.
Join this webinar that promises to be as informative as it is impactful, providing attendees with the knowledge and strategies to enhance the effectiveness and sensitivity of clinical trials in pediatric epilepsy.
Keywords: Drug Development, Clinical Research, CRO, Clinical Data, Therapeutic Areas, CNS, Clinical Endpoints, Endpoints, Seizures, Clinical Trial Endpoints, Epileptic Seizures
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Juliane Mills, MPH, Senior Director Therapeutic Strategy, Worldwide Clinical Trials
Gabi Conecker, MPH, Executive Director & Co-Director, Decoding Developmental Epilepsies
JayEtta Hecker, MS, Executive Director & Co-Director, Decoding Developmental Epilepsies
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2025-01-22
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|